26 Apr 2026 bundleStory 2 of 5
INTERNATIONALHIGH PRIORITYUPSC · HighSSC · HighBanking · LowRailway · HighDefence · Low

WORLD MALARIA DAY 2026 — observed on 25 APRIL — was marked under the theme 'DRIVEN TO END MALARIA: NOW WE CAN. NOW WE MUST.', highlighting scientific progress (vaccines like RTS,S and the newer R21) and stressing that malaria elimination is achievable with collective effort; the day was established by the WORLD HEALTH ORGANIZATION (WHO), replacing the earlier Africa Malaria Day; global progress includes 47 countries certified malaria-free, 37 countries reporting fewer than 1,000 cases in 2024, expansion of vaccination programmes in 25+ countries, and ~610,000 malaria deaths globally in 2024; the WHO Global Technical Strategy (2016-2030) targets a 90% reduction in malaria cases and deaths by 2030; INDIA recorded an 80% reduction in malaria cases (2015-2023) and exited the High Burden to High Impact (HBHI) group in 2024.

विश्व मलेरिया दिवस 2026 — 25 अप्रैल को मनाया गया — विषय 'मलेरिया समाप्त करने के लिए प्रेरित: अब हम कर सकते हैं। अब हमें करना ही है।' के तहत मनाया गया, वैज्ञानिक प्रगति (RTS,S एवं नए R21 जैसे टीके) को उजागर करते हुए एवं इस पर ज़ोर देते हुए कि सामूहिक प्रयासों से मलेरिया उन्मूलन प्राप्त किया जा सकता है; यह दिवस विश्व स्वास्थ्य संगठन (WHO) द्वारा स्थापित, पूर्व अफ़्रीका मलेरिया दिवस का स्थान लिया; वैश्विक प्रगति में 47 देश मलेरिया-मुक्त प्रमाणित, 37 देशों में 2024 में 1,000 से कम मामले, 25+ देशों में टीकाकरण कार्यक्रमों का विस्तार, एवं 2024 में वैश्विक स्तर पर ~610,000 मलेरिया मौतें शामिल हैं; WHO वैश्विक तकनीकी रणनीति (2016-2030) का लक्ष्य 2030 तक मलेरिया मामलों एवं मौतों में 90% कमी; भारत ने 2015-2023 में मलेरिया मामलों में 80% कमी दर्ज की एवं 2024 में उच्च बोझ से उच्च प्रभाव (HBHI) समूह से बाहर निकल गया।

·Reportage on World Malaria Day 2026 — observance, theme, and global progress against malaria; references World Health Organization (WHO), Global Technical Strategy 2016-2030, India's National Vector Borne Disease Control Programme

Why in News

WORLD MALARIA DAY 2026 was observed globally on 25 APRIL 2026 — a date dedicated to raising awareness about malaria and accelerating global efforts toward its elimination. THE 2026 THEME: 'DRIVEN TO END MALARIA: NOW WE CAN. NOW WE MUST.' — highlighting scientific progress including vaccines and improved diagnostics; emphasising urgent global action and funding; reinforcing that malaria elimination is achievable with collective effort across governments, healthcare institutions, and global organisations. ESTABLISHMENT: World Malaria Day was established by the WORLD HEALTH ORGANIZATION (WHO), REPLACING the earlier AFRICA MALARIA DAY which had been observed since 2001 in line with the Abuja Declaration. The transition to a global observance reflected malaria's worldwide significance. GLOBAL PROGRESS in malaria control: (1) 47 COUNTRIES certified malaria-free by WHO; (2) 37 COUNTRIES reported fewer than 1,000 malaria cases in 2024; (3) Expansion of VACCINATION PROGRAMMES in 25+ COUNTRIES (using RTS,S and newer R21 vaccines); (4) Increased use of INSECTICIDE-TREATED MOSQUITO NETS (ITNs) — 84% of distributed nets are advanced ITNs; (5) Strong healthcare systems, effective surveillance, and political commitment have been the backbone of successful strategies. UNDERSTANDING MALARIA: Malaria is caused by PLASMODIUM PARASITES, transmitted through the bite of infected female ANOPHELES MOSQUITOES. Five species infect humans: Plasmodium falciparum (most deadly), P. vivax (causes relapsing malaria), P. malariae, P. ovale, P. knowlesi. Severe cases may lead to organ failure or death. VACCINES: (a) RTS,S — first malaria vaccine, 30-40% effective; (b) R21 — newer and more scalable vaccine. EARLY DIAGNOSIS and treatment with antimalarial drugs are critical. GLOBAL MALARIA STATISTICS: approximately 610,000 malaria deaths globally in 2024; nearly 10 MILLION children targeted annually for vaccination; 84% of mosquito nets distributed are advanced ITNs. Despite progress, malaria remains a major global health burden — especially in sub-Saharan Africa and parts of Asia. WHO GLOBAL TECHNICAL STRATEGY (2016-2030): targets a 90% REDUCTION in malaria cases and deaths by 2030; aims to eliminate malaria in multiple countries; prevent resurgence in malaria-free regions. Key pillars: (1) Vector control (nets, indoor residual spraying); (2) Early diagnosis and treatment; (3) Surveillance and data-driven policies. STATUS OF MALARIA IN INDIA: 80% REDUCTION in malaria cases (2015-2023); India EXITED THE HIGH BURDEN TO HIGH IMPACT (HBHI) GROUP in 2024 — a major milestone; over 90% reduction in deaths; National Vector Borne Disease Control Programme (NVBDCP) — reorganised as National Centre for Vector Borne Diseases Control (NCVBDC) — coordinates national efforts under the Ministry of Health and Family Welfare; India targets MALARIA ELIMINATION BY 2030. The MALARIA ELIMINATION RESEARCH ALLIANCE (MERA) coordinates research efforts in India. The day's observance comes amid growing momentum: increasing vaccine deployment, gene-drive research advances (with field studies in Tanzania showing GM mosquitoes can block parasite transmission), and digital health-data integration improving surveillance.

At a Glance

Date
25 April 2026
Theme 2026
'Driven to End Malaria: Now We Can. Now We Must.'
Established by
World Health Organization (WHO)
Replaced
Africa Malaria Day (which had been observed since 2001)
Causative agent
Plasmodium parasites — transmitted by infected female Anopheles mosquitoes
Most deadly species
Plasmodium falciparum
Most widespread species (incl. India)
Plasmodium vivax (causes relapsing malaria)
First malaria vaccine
RTS,S (30-40% effective)
Newer scalable vaccine
R21 — more scalable than RTS,S
Malaria-free certified countries
47 countries (WHO certification)
Countries with <1,000 cases (2024)
37 countries
Vaccination programme countries
25+ countries
Annual deaths globally (2024)
Approximately 610,000
WHO Global Technical Strategy 2016-2030
Reduce malaria cases and deaths by 90% by 2030
India progress (2015-2023)
80% reduction in malaria cases
India HBHI exit
2024 — exited High Burden to High Impact group
India target
Malaria elimination by 2030
Key Fact

WORLD MALARIA DAY 2026 was observed globally on 25 APRIL — a day dedicated to raising awareness about malaria and accelerating global efforts toward its elimination. The 2026 theme: 'DRIVEN TO END MALARIA: NOW WE CAN. NOW WE MUST.' — highlighting scientific progress (vaccines, diagnostics) and stressing that elimination is achievable with collective effort. ESTABLISHMENT: World Malaria Day was established by the WORLD HEALTH ORGANIZATION (WHO) — first observed in 2008 (replacing AFRICA MALARIA DAY which had been marked since 2001 in line with the Abuja Declaration). The transition reflected malaria's worldwide significance beyond Africa. UNDERSTANDING MALARIA: Caused by PLASMODIUM PARASITES — five species infect humans: P. FALCIPARUM (most lethal, dominant in Africa), P. VIVAX (most widespread globally, including India; causes relapsing malaria), P. MALARIAE, P. OVALE, P. KNOWLESI (zoonotic). Transmitted by infected female ANOPHELES MOSQUITOES (only female mosquitoes bite humans; males feed on plant nectar). Severe cases lead to cerebral malaria, organ failure, or death. VACCINES: (1) RTS,S — first malaria vaccine, recommended by WHO in October 2021; about 30-40% effective; manufactured by GlaxoSmithKline; (2) R21 — second malaria vaccine, recommended by WHO in October 2023; more scalable and lower-cost; manufactured by Serum Institute of India. GLOBAL PROGRESS: (a) 47 COUNTRIES certified malaria-free by WHO; (b) 37 COUNTRIES reported fewer than 1,000 cases in 2024; (c) Expansion of vaccination programmes in 25+ COUNTRIES; (d) 84% of distributed mosquito nets are advanced INSECTICIDE-TREATED NETS (ITNs); (e) Approximately 610,000 malaria deaths globally in 2024; (f) Nearly 10 MILLION CHILDREN targeted annually for vaccination. Despite progress, malaria remains a major global health burden — sub-Saharan Africa accounts for approximately 95% of cases and deaths globally. THE WHO GLOBAL TECHNICAL STRATEGY FOR MALARIA 2016-2030 sets ambitious targets: REDUCE MALARIA INCIDENCE by AT LEAST 90% BY 2030 (vs 2015 baseline); REDUCE MALARIA MORTALITY by AT LEAST 90% BY 2030; ELIMINATE MALARIA from at least 35 countries; PREVENT RE-ESTABLISHMENT in countries that are malaria-free. Three pillars: (1) ENSURE UNIVERSAL ACCESS to malaria prevention, diagnosis, and treatment; (2) ACCELERATE EFFORTS toward elimination and attainment of malaria-free status; (3) TRANSFORM MALARIA SURVEILLANCE into a core intervention. KEY VECTOR-CONTROL TOOLS: (a) Insecticide-Treated Nets (ITNs) — also called Long-Lasting Insecticidal Nets (LLINs); (b) Indoor Residual Spraying (IRS); (c) Larval source management; (d) Targeted vector-control interventions. INDIA'S PROGRESS: (1) 80% REDUCTION in malaria cases between 2015 and 2023 — among the strongest national declines globally; (2) Over 90% reduction in malaria deaths over the same period; (3) India EXITED THE HIGH BURDEN TO HIGH IMPACT (HBHI) GROUP IN 2024 — a milestone marking transition from high-burden country status; (4) India targets MALARIA ELIMINATION BY 2030 — aligned with WHO Global Technical Strategy. INDIAN PROGRAMMES: (a) National Vector Borne Disease Control Programme (NVBDCP) — reorganised as NATIONAL CENTRE FOR VECTOR BORNE DISEASES CONTROL (NCVBDC) under Ministry of Health and Family Welfare; (b) MALARIA ELIMINATION RESEARCH ALLIANCE (MERA-INDIA) — established under the Indian Council of Medical Research (ICMR) for coordinated research; (c) National Framework for Malaria Elimination (2016-2030); (d) Long-Lasting Insecticidal Net (LLIN) distribution; (e) Surveillance through SIH (Surveillance, Investigation and Health-care) systems. INDIAN VECTOR CONTEXT: Major Anopheles vectors in India include A. CULICIFACIES (rural plains, dominant in northern India), A. STEPHENSI (urban malaria, including in cities; recently spread to East Africa raising new concerns), A. FLUVIATILIS, A. MINIMUS, A. DIRUS (forest areas of Northeast). HISTORICAL FIGURES: (i) RONALD ROSS demonstrated in 1897 that mosquitoes transmit malaria — Nobel Prize in Physiology or Medicine 1902; (ii) CHARLES LAVERAN discovered the Plasmodium parasite in 1880 — Nobel Prize 1907. KEY CHALLENGES: drug resistance (P. falciparum to artemisinin-based combination therapies); insecticide resistance in mosquitoes; inadequate health system capacity in remote areas; climate-change-driven vector range expansion (A. stephensi spread to new areas); funding constraints. Recent advances include gene-drive research (with field studies showing GM mosquitoes can block parasite transmission, e.g., in Tanzania), monoclonal antibodies for malaria prevention, and improved rapid diagnostic tests. For UPSC and SSC contexts, this is a priority topic across health policy, India's vector-borne disease programmes, WHO governance, public-health vaccine politics, and SDG 3 (Good Health and Well-being).

विश्व मलेरिया दिवस 2026 = 25 अप्रैल को वैश्विक स्तर पर मनाया गया। 2026 का विषय: 'मलेरिया समाप्त करने के लिए प्रेरित: अब हम कर सकते हैं। अब हमें करना ही है।' स्थापना: विश्व स्वास्थ्य संगठन (WHO) द्वारा; पहली बार 2008 में मनाया गया (पूर्व अफ़्रीका मलेरिया दिवस का स्थान लिया, जो 2001 से मनाया जा रहा था)। मलेरिया कारण: PLASMODIUM परजीवी, संक्रमित मादा ANOPHELES मच्छरों द्वारा संचारित। 5 मानव-संक्रमित प्रजातियाँ: P. falciparum (सबसे घातक, अफ़्रीका में प्रमुख), P. vivax (सबसे व्यापक, भारत में; पुनरावर्ती मलेरिया), P. malariae, P. ovale, P. knowlesi (पशुजन्य)। टीके: (1) RTS,S — पहला मलेरिया टीका; WHO द्वारा अक्टूबर 2021 में सिफ़ारिश; 30-40% प्रभावी; GlaxoSmithKline (2) R21 — दूसरा टीका; WHO द्वारा अक्टूबर 2023 में सिफ़ारिश; अधिक व्यापक; Serum Institute of India। वैश्विक प्रगति: 47 देश मलेरिया-मुक्त प्रमाणित; 37 देशों में 2024 में 1,000 से कम मामले; 25+ देशों में टीकाकरण; 2024 में ~610,000 वैश्विक मौतें; 84% वितरित मच्छरदानी ITNs। WHO वैश्विक तकनीकी रणनीति 2016-2030: 2030 तक मलेरिया मामलों एवं मौतों में 90% कमी; 35+ देशों से उन्मूलन। भारत: 2015-2023 में 80% मामलों में कमी; 2024 में HBHI समूह से बाहर; 2030 तक मलेरिया उन्मूलन लक्ष्य; NVBDCP/NCVBDC; MERA-India (ICMR के तहत)। मच्छर वाहक: A. culicifacies (ग्रामीण), A. stephensi (शहरी), A. fluviatilis, A. minimus, A. dirus। ऐतिहासिक: रोनाल्ड रॉस 1897 (मच्छर-मलेरिया, नोबेल 1902); चार्ल्स लेवरन 1880 (Plasmodium खोज, नोबेल 1907)।

World Malaria Day 2026 — at a glance
विश्व मलेरिया दिवस 2026 — एक नज़र में
25 April
Annual observance date
वार्षिक तिथि
47 countries
WHO-certified malaria-free
मलेरिया-मुक्त प्रमाणित
80% reduction
India 2015-2023; exited HBHI 2024
भारत 80% कमी
~610K deaths
Global malaria deaths 2024
वैश्विक मौतें 2024
Malaria vaccines — RTS,S vs R21
मलेरिया टीके — RTS,S बनाम R21
Aspect
पहलू
RTS,S (Mosquirix)
RTS,S
R21 (R21/Matrix-M)
R21
WHO recommendation
WHO सिफ़ारिश
October 2021 (first)
अक्टूबर 2021 (पहला)
October 2023 (second)
अक्टूबर 2023 (दूसरा)
Manufacturer
निर्माता
GlaxoSmithKline
GlaxoSmithKline
Serum Institute of India + Univ of Oxford
SII + Oxford
Effectiveness
प्रभावशीलता
30-40%
30-40%
Higher; more scalable
अधिक; अधिक स्केलेबल
Cost
लागत
Higher per dose
उच्च प्रति खुराक
Lower per dose
कम प्रति खुराक

Static GK

  • •World Malaria Day: Annual global observance on 25 April; established by WHO; first observed in 2008 by WHO Member States; replaced Africa Malaria Day (observed since 2001 in line with Abuja Declaration)
  • •World Malaria Day 2026 theme: 'Driven to End Malaria: Now We Can. Now We Must.' — highlighting scientific progress (vaccines, diagnostics) and stressing collective action
  • •World Health Organization (WHO): UN specialised agency for international public health; founded 7 April 1948 (date observed as World Health Day); HQ Geneva, Switzerland; 194 member states; current Director-General Dr Tedros Adhanom Ghebreyesus (since 2017)
  • •Plasmodium parasites — five species infecting humans: P. falciparum (most lethal, dominant in Africa); P. vivax (most widespread globally, including India; causes relapsing malaria); P. malariae; P. ovale; P. knowlesi (zoonotic, primarily Southeast Asia)
  • •Anopheles mosquitoes — major Indian vectors: A. culicifacies (rural plains, dominant North India); A. stephensi (urban malaria; recently spread to East Africa); A. fluviatilis; A. minimus; A. dirus (forest areas of Northeast)
  • •RTS,S vaccine: First malaria vaccine recommended by WHO in October 2021; about 30-40% effective; manufactured by GlaxoSmithKline; trade name Mosquirix
  • •R21 vaccine: Second malaria vaccine recommended by WHO in October 2023; more scalable and lower-cost than RTS,S; manufactured by Serum Institute of India in collaboration with University of Oxford; full name R21/Matrix-M
  • •WHO Global Technical Strategy for Malaria 2016-2030: Targets: REDUCE malaria incidence and mortality BY AT LEAST 90% BY 2030 (vs 2015 baseline); ELIMINATE malaria from at least 35 countries; PREVENT re-establishment in malaria-free countries
  • •Global malaria burden (WHO 2024 estimates for 2023): Approximately 263 million cases globally + ~597,000 deaths in 2023 (per World Malaria Report 2024); approximately 610,000 malaria deaths in 2024; sub-Saharan Africa accounts for ~95% of cases and deaths globally
  • •Malaria-free certified countries: 47 countries certified malaria-free by WHO; 37 countries reported fewer than 1,000 cases in 2024; vaccination programmes in 25+ countries
  • •India's malaria progress: 80% REDUCTION in malaria cases (2015-2023); over 90% reduction in deaths; EXITED High Burden to High Impact (HBHI) GROUP in 2024; targets MALARIA ELIMINATION BY 2030
  • •National Centre for Vector Borne Diseases Control (NCVBDC): Reorganisation of the former National Vector Borne Disease Control Programme (NVBDCP); under the Ministry of Health and Family Welfare; coordinates national efforts on malaria, dengue, chikungunya, kala-azar, lymphatic filariasis, Japanese encephalitis
  • •MERA-India: Malaria Elimination Research Alliance — India; established under the Indian Council of Medical Research (ICMR); coordinates malaria research across institutions
  • •National Framework for Malaria Elimination (2016-2030): India's strategic framework aligned with WHO Global Technical Strategy; phased approach toward malaria elimination by 2030
  • •Insecticide-Treated Nets (ITNs): Mosquito nets treated with long-lasting insecticide; key vector-control tool; advanced ITNs (also called Long-Lasting Insecticidal Nets / LLINs) constitute 84% of distributed nets globally
  • •Ronald Ross: British medical doctor; demonstrated in 1897 that female Anopheles mosquitoes transmit malaria parasites — Nobel Prize in Physiology or Medicine 1902 (the second Nobel in this category)
  • •Charles Laveran: French military doctor; discovered the Plasmodium parasite in 1880 in Algeria — Nobel Prize in Physiology or Medicine 1907
  • •World Health Day: Different observance from World Malaria Day; observed annually on 7 April commemorating WHO founding (1948); both are WHO-led observances

Timeline

  1. 1880
    Charles Laveran discovers Plasmodium parasite in Algeria — Nobel Prize 1907.
  2. 1897
    Ronald Ross demonstrates female Anopheles mosquitoes transmit malaria — Nobel Prize 1902.
  3. 7 April 1948
    World Health Organization (WHO) founded; date observed annually as World Health Day.
  4. 2001
    Africa Malaria Day established under the Abuja Declaration (African Heads of State commitment to malaria control).
  5. 2007
    WHO World Health Assembly resolution establishes WORLD MALARIA DAY (replacing Africa Malaria Day).
  6. 2008
    First World Malaria Day observed globally on 25 April.
  7. 2015
    WHO Global Technical Strategy for Malaria 2016-2030 adopted; baseline year for 90% reduction targets.
  8. October 2021
    WHO recommends RTS,S as first malaria vaccine for use in children.
  9. October 2023
    WHO recommends R21 as second malaria vaccine — more scalable and lower-cost.
  10. 2024
    India exits the High Burden to High Impact (HBHI) group; 80% reduction in malaria cases (vs 2015 baseline) achieved.
  11. 25 April 2026
    World Malaria Day 2026 observed under theme 'Driven to End Malaria: Now We Can. Now We Must.'
Mnemonic · Memory Hooks
  • →DATE = 25 APRIL annually.
  • →2026 THEME: 'DRIVEN TO END MALARIA: NOW WE CAN. NOW WE MUST.'
  • →Established by = WORLD HEALTH ORGANIZATION (WHO). FIRST OBSERVED = 2008. REPLACED = AFRICA MALARIA DAY (since 2001, Abuja Declaration).
  • →WHO founded = 7 APRIL 1948 (HQ Geneva). World Health Day = 7 April (different from World Malaria Day).
  • →MALARIA CAUSE: PLASMODIUM parasites + transmitted by infected female ANOPHELES mosquitoes.
  • →5 PLASMODIUM SPECIES infecting humans: (1) P. FALCIPARUM = most lethal (Africa) (2) P. VIVAX = most widespread (incl India; relapsing malaria) (3) P. MALARIAE (4) P. OVALE (5) P. KNOWLESI = zoonotic (SE Asia).
  • →MAIN INDIAN ANOPHELES VECTORS: (1) A. CULICIFACIES (rural plains, dominant N India) (2) A. STEPHENSI (urban malaria; recently spread to East Africa) (3) A. fluviatilis (4) A. minimus (5) A. dirus (NE forest).
  • →VACCINES: (1) RTS,S = FIRST malaria vaccine. WHO recommended OCT 2021. 30-40% effective. GLAXOSMITHKLINE. Trade name MOSQUIRIX. (2) R21 = SECOND vaccine. WHO recommended OCT 2023. MORE SCALABLE. SERUM INSTITUTE OF INDIA + Univ of Oxford. R21/Matrix-M.
  • →GLOBAL PROGRESS: 47 COUNTRIES certified malaria-free. 37 countries <1,000 cases in 2024. 25+ countries vaccination programmes. 84% distributed nets are ITNs.
  • →GLOBAL DEATHS = ~610,000 in 2024. ~263 MILLION cases globally in 2023 per WHO World Malaria Report 2024. Sub-Saharan Africa = ~95% of cases and deaths.
  • →10 MILLION CHILDREN targeted annually for vaccination.
  • →WHO GLOBAL TECHNICAL STRATEGY for MALARIA 2016-2030: REDUCE incidence + mortality by 90% BY 2030 (vs 2015 baseline). ELIMINATE from 35+ countries. PREVENT re-establishment.
  • →3 PILLARS of WHO Strategy: (1) Universal access to prevention/diagnosis/treatment (2) Accelerate elimination (3) Transform surveillance into core intervention.
  • →INDIA'S PROGRESS: 80% REDUCTION 2015-2023. >90% reduction in deaths. EXITED HBHI (High Burden to High Impact) group in 2024. Target = MALARIA ELIMINATION BY 2030.
  • →INDIA INSTITUTIONS: NVBDCP → NCVBDC (National Centre for Vector Borne Diseases Control) under MoHFW. National Framework for Malaria Elimination 2016-2030.
  • →MERA-INDIA = MALARIA ELIMINATION RESEARCH ALLIANCE — INDIA. Under ICMR. Coordinates malaria research.
  • →VECTOR CONTROL: ITNs (Insecticide-Treated Nets) / LLINs (Long-Lasting Insecticidal Nets) + IRS (Indoor Residual Spraying) + larval source management.
  • →HISTORICAL FIGURES: (1) RONALD ROSS 1897 — demonstrated mosquitoes transmit malaria. Nobel 1902 (2nd in Physiology/Medicine). (2) CHARLES LAVERAN 1880 — discovered Plasmodium parasite. Nobel 1907.

Exam Angles

SSC / Railway

World Malaria Day 2026 was observed on 25 April under the theme 'Driven to End Malaria: Now We Can. Now We Must.'; established by the WHO (replacing Africa Malaria Day, first observed 2008); 47 countries certified malaria-free; 37 countries reported <1,000 cases in 2024; ~610,000 deaths globally in 2024; sub-Saharan Africa accounts for ~95%; WHO Global Technical Strategy 2016-2030 targets 90% reduction by 2030; vaccines RTS,S (WHO 2021, 30-40% effective) and R21 (WHO 2023, more scalable, Serum Institute of India); India achieved 80% reduction (2015-2023) and exited High Burden to High Impact (HBHI) group in 2024; targets malaria elimination by 2030 under NVBDCP/NCVBDC; MERA-India under ICMR coordinates research.

Practice (4)

Q1. World Malaria Day is observed annually on which date and was established by which body?

  1. A.7 April — World Health Organization
  2. B.25 April — World Health Organization
  3. C.1 December — UNAIDS
  4. D.24 March — Stop TB Partnership
tap to reveal answer

Answer: B. 25 April — World Health Organization

World Malaria Day is observed annually on 25 April. It was established by the World Health Organization (WHO), first observed in 2008, and replaced the earlier Africa Malaria Day (which had been observed since 2001 in line with the Abuja Declaration). World Health Day (7 April), World AIDS Day (1 December), and World TB Day (24 March) are different observances.

Q2. The 2026 theme of World Malaria Day is:

  1. A.'Zero Malaria Starts With Me'
  2. B.'Malaria-Free World Begins With You'
  3. C.'Driven to End Malaria: Now We Can. Now We Must.'
  4. D.'Beat Malaria Together'
tap to reveal answer

Answer: C. 'Driven to End Malaria: Now We Can. Now We Must.'

The 2026 theme of World Malaria Day is 'Driven to End Malaria: Now We Can. Now We Must.' — highlighting scientific progress (vaccines, diagnostics) and stressing that elimination is achievable with collective effort across governments, healthcare institutions, and global organisations.

Q3. The first malaria vaccine recommended by the World Health Organization (WHO) in October 2021 — about 30-40% effective — is:

  1. A.BCG
  2. B.RTS,S (Mosquirix)
  3. C.R21/Matrix-M
  4. D.Covishield
tap to reveal answer

Answer: B. RTS,S (Mosquirix)

RTS,S (trade name Mosquirix), manufactured by GlaxoSmithKline, was the FIRST malaria vaccine recommended by WHO in October 2021 — about 30-40% effective. The R21/Matrix-M vaccine was the SECOND, recommended by WHO in October 2023 — more scalable and lower-cost, manufactured by Serum Institute of India in collaboration with the University of Oxford. BCG is for tuberculosis; Covishield is for COVID-19.

Q4. Ronald Ross — who demonstrated in 1897 that mosquitoes transmit malaria — received the Nobel Prize in Physiology or Medicine in:

  1. A.1900
  2. B.1902
  3. C.1907
  4. D.1923
tap to reveal answer

Answer: B. 1902

Ronald Ross received the Nobel Prize in Physiology or Medicine in 1902 — the second Nobel in this category. He demonstrated in 1897 that female Anopheles mosquitoes transmit malaria parasites. Charles Laveran (who discovered the Plasmodium parasite in 1880 in Algeria) received the Nobel Prize in 1907. Both contributed foundational work to malaria science.

UPSC Mains
GS-II: Issues relating to development and management of Social Sector/Services relating to HealthGS-II: Important International institutions, agencies and fora — their structure, mandate (WHO)GS-III: Science and Technology — developments and their applications and effects in everyday life (vaccines, biotechnology)GS-III: Issues relating to direct and indirect farm subsidies and minimum support prices; Public Distribution System and issues therein (vector control infrastructure)GS-II: Government policies and interventions for development in various sectors

WORLD MALARIA DAY — observed on 25 APRIL annually — commemorates global efforts to combat MALARIA, established by the WORLD HEALTH ORGANIZATION (WHO) in 2007 (replacing the earlier Africa Malaria Day, observed since 2001). The 2026 theme — 'DRIVEN TO END MALARIA: NOW WE CAN. NOW WE MUST.' — emphasises scientific progress (vaccines like RTS,S and the newer R21), urgent global action, and accountability among governments, healthcare institutions, and global organisations. THE GLOBAL BURDEN: approximately 263 million malaria cases globally with about 597,000 deaths in 2023 (per WHO World Malaria Report 2024); some sources reference around 610,000 deaths in 2024. SUB-SAHARAN AFRICA accounts for ~95% of cases and deaths; children under 5 are particularly vulnerable. PARASITE BIOLOGY: malaria is caused by PLASMODIUM PARASITES (5 species infecting humans — P. falciparum most lethal, P. vivax most widespread including India, P. malariae, P. ovale, P. knowlesi zoonotic) transmitted by infected female ANOPHELES MOSQUITOES. VACCINES: RTS,S (first malaria vaccine, 30-40% effective); R21 (newer, more scalable, also approved by WHO). VECTOR CONTROL: insecticide-treated mosquito nets (ITNs) — 84% of nets distributed are advanced ITNs; indoor residual spraying. WHO GLOBAL TECHNICAL STRATEGY (2016-2030) targets: reduce malaria cases and deaths by 90% by 2030; eliminate malaria in multiple countries; prevent resurgence in malaria-free regions. GLOBAL PROGRESS: 47 countries certified malaria-free; 37 countries reported fewer than 1,000 cases in 2024; vaccination programmes expanded in 25+ countries. INDIA'S PROGRESS: 80% reduction in malaria cases (2015-2023); EXIT FROM HIGH BURDEN TO HIGH IMPACT (HBHI) GROUP in 2024 — significant milestone. India's malaria control architecture: NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME (NVBDCP) reorganised as NATIONAL CENTRE FOR VECTOR BORNE DISEASES CONTROL (NCVBDC) under Ministry of Health and Family Welfare. India's MALARIA ELIMINATION FRAMEWORK (2016-2030) aligns with WHO targets — malaria-free India by 2030. The MALARIA ELIMINATION RESEARCH ALLIANCE (MERA) coordinates research across Indian institutions. CHALLENGES: insecticide resistance in Anopheles vectors; drug resistance in Plasmodium parasites; climate change altering vector distribution; emergence of A. stephensi as urban malaria vector in South Asia and recently in East Africa; funding gaps in vaccination scale-up; surveillance gaps in remote/tribal areas; intersection with other vector-borne diseases (dengue, chikungunya, Zika). EMERGING APPROACHES: gene-drive mosquitoes (CRISPR-Cas9 based — research in early stages, governed by Cartagena Protocol on Biosafety 2000); next-generation vaccines and combination therapies; community-based surveillance. POLICY THEMES: India's exit from HBHI 2024 marks transition from high-burden to elimination phase requiring different strategies (high-resolution surveillance, hotspot focus, imported-case management). For UPSC, the topic spans GS-II (health policy, WHO, government interventions) and GS-III (science of vaccines, biotechnology applications).

Dimensions
  • WHO observance and 2026 themeWorld Malaria Day on 25 April; established 2007 (replaced Africa Malaria Day); 2026 theme 'Driven to End Malaria: Now We Can. Now We Must.'
  • Global burden~263 million cases + ~597K deaths in 2023; sub-Saharan Africa ~95%; children <5 most vulnerable.
  • Parasite-vector biology5 Plasmodium species (P. falciparum most lethal, P. vivax most widespread); transmitted by female Anopheles mosquitoes.
  • Vaccine progressRTS,S (first, 30-40% effective); R21 (newer, scalable); WHO-approved.
  • Vector controlITNs (84% advanced); indoor residual spraying; integrated vector management.
  • WHO Global Technical Strategy (2016-2030)90% reduction in cases and deaths by 2030; eliminate in multiple countries; prevent resurgence.
  • Global progress47 countries certified malaria-free; 37 with <1,000 cases in 2024; vaccination in 25+ countries.
  • India's 80% reduction (2015-2023)Significant decline; exit from HBHI group 2024; transition to elimination phase.
  • India's institutional architectureNVBDCP → NCVBDC under MoHFW; MERA research alliance; National Framework for Malaria Elimination 2016-2030.
  • Emerging challengesInsecticide resistance + drug resistance + climate change + A. stephensi urban spread + funding gaps.
  • Emerging approachesGene-drive mosquitoes (CRISPR-Cas9); next-generation vaccines; community surveillance.
  • Cross-cutting linkagesClimate change, urbanisation, equity in healthcare, biosafety regulation, multilateral cooperation.
Challenges
  • Insecticide resistance in Anopheles vectors threatening ITN/IRS efficacy.
  • Drug resistance in Plasmodium parasites — particularly artemisinin-resistance signals in Southeast Asia.
  • Climate change altering Anopheles distribution and seasonal dynamics.
  • Anopheles stephensi (urban malaria vector) spreading from South Asia to East Africa — new urban malaria risk.
  • Funding gaps in vaccine scale-up and procurement.
  • Surveillance gaps in remote, tribal, and conflict-affected areas.
  • Imported cases and cross-border transmission management in elimination-phase countries.
  • Intersection with other vector-borne diseases (dengue, chikungunya, Zika) requiring integrated vector management.
  • Reduced political attention as cases decline — risk of resurgence.
  • Health-system gaps in rural diagnostic and treatment delivery.
  • Equity: high mortality concentrated among children under 5 in low-income countries.
Way Forward
  • Sustain political and financial commitment through elimination phase (avoid 'success trap').
  • Scale up RTS,S and R21 vaccines in malaria-endemic regions.
  • Strengthen integrated vector management — ITNs, IRS, larval source management.
  • Robust surveillance — high-resolution, hotspot-focused, real-time.
  • Cross-border coordination for elimination-phase countries.
  • Address insecticide and drug resistance through new tools and rotation strategies.
  • Continue research and biosafety oversight for gene-drive mosquito approaches.
  • Strengthen WHO Global Malaria Programme and Global Fund coordination.
  • Climate-adaptation planning for malaria endemic-zone shifts.
  • Address A. stephensi urban malaria threat in South Asia and East Africa.
  • Community engagement and equity focus — particularly children under 5.
  • India: continued NCVBDC strengthening, MERA-coordinated research, malaria-free India by 2030 target.
Mains Q · 250w

World Malaria Day 2026 — observed under the theme 'Driven to End Malaria: Now We Can. Now We Must.' — highlights both progress and persistent challenges in global malaria control. Discuss India's strategy for malaria elimination by 2030 and the role of emerging interventions including vaccines and gene-drive mosquitoes. (250 words)

Intro: World Malaria Day, observed on 25 April annually since 2007 (replacing Africa Malaria Day), is marked in 2026 under the theme 'Driven to End Malaria: Now We Can. Now We Must.' Despite ~263 million cases and ~597K deaths in 2023 globally (~95% in sub-Saharan Africa), progress is real — 47 countries certified malaria-free; vaccines like RTS,S and R21 deployed; India achieved 80% reduction (2015-2023) and exited the HBHI group in 2024.

  • Global framework: WHO Global Technical Strategy (2016-2030) targets 90% reduction in cases and deaths by 2030.
  • Parasite-vector biology: 5 Plasmodium species (P. falciparum most lethal, P. vivax most widespread including India); transmitted by female Anopheles mosquitoes.
  • Vaccines: RTS,S (first, 30-40% effective), R21 (newer, scalable); 25+ countries with vaccination programmes.
  • Vector control: ITNs (84% advanced), indoor residual spraying, integrated vector management.
  • India's strategy: National Framework for Malaria Elimination 2016-2030; NVBDCP/NCVBDC under MoHFW; MERA research alliance; goal of malaria-free India by 2030.
  • Emerging interventions: gene-drive mosquitoes (CRISPR-Cas9 based) for population suppression or modification — research stage, governed by Cartagena Protocol on Biosafety; next-generation combination therapies.
  • Challenges: insecticide and drug resistance; climate change; A. stephensi urban spread; funding gaps; surveillance gaps in remote areas.
  • Way forward: sustain commitment through elimination; scale vaccines; integrated vector management; cross-border coordination; community engagement; biosafety-cleared research on next-generation tools.

Conclusion: Malaria elimination by 2030 is achievable but requires sustained political will, scientific innovation, equitable access, and integrated public health systems. India's HBHI exit and 80% case reduction provide a credible pathway — backed by NCVBDC, MERA, and emerging tools. As the 2026 theme insists: 'Now We Can. Now We Must.'

Common Confusions

  • Trap · World Malaria Day vs World Health Day

    Correct: World Malaria Day = 25 APRIL annually. World Health Day = 7 APRIL annually (commemorates WHO founding 1948). Both are WHO-led but distinct observances.

  • Trap · World Malaria Day establishment

    Correct: Established by WHO; FIRST OBSERVED in 2008 (per WHO World Health Assembly resolution 2007). REPLACED Africa Malaria Day (which had been observed since 2001 in line with Abuja Declaration). Don't say 2001 or 2007 as 'first observed'.

  • Trap · RTS,S vs R21 — order and recommender dates

    Correct: RTS,S = FIRST malaria vaccine; WHO recommended OCTOBER 2021; ~30-40% effective; manufactured by GlaxoSmithKline; trade name Mosquirix. R21 = SECOND; WHO recommended OCTOBER 2023; more scalable and lower-cost; manufactured by Serum Institute of India + University of Oxford. Don't reverse.

  • Trap · Plasmodium species — most deadly vs most widespread

    Correct: P. FALCIPARUM = MOST DEADLY (dominant in Africa). P. VIVAX = MOST WIDESPREAD globally and dominant in India; CAUSES RELAPSING MALARIA. Different metrics — don't conflate.

  • Trap · Number of Plasmodium species infecting humans

    Correct: FIVE species: P. falciparum, P. vivax, P. malariae, P. ovale, P. knowlesi (zoonotic, primarily SE Asia). Don't say 4 or 6.

  • Trap · Anopheles vectors in India — major species

    Correct: A. CULICIFACIES (rural plains, dominant N India) + A. STEPHENSI (urban malaria; recently spread to East Africa) + A. fluviatilis + A. minimus + A. dirus (NE forest). A. gambiae is the AFRICAN vector — NOT India.

  • Trap · WHO Global Technical Strategy targets

    Correct: REDUCE malaria incidence + mortality by AT LEAST 90% BY 2030 (vs 2015 baseline). NOT 50% or 70%. Eliminate from 35+ countries. Prevent re-establishment.

  • Trap · India HBHI exit

    Correct: INDIA EXITED THE HIGH BURDEN TO HIGH IMPACT (HBHI) GROUP IN 2024 — major milestone. NOT 2015 or 2030. Came after the 80% case reduction over 2015-2023.

  • Trap · India's malaria target

    Correct: MALARIA ELIMINATION BY 2030 — aligned with WHO Global Technical Strategy. NOT 2025 or 2040. Part of the National Framework for Malaria Elimination 2016-2030.

  • Trap · Global malaria deaths in 2024

    Correct: Approximately 610,000 deaths in 2024 (per source reportage). The WHO World Malaria Report 2024 reported ~597,000 deaths for 2023 — figures change year-on-year.

  • Trap · MERA-India institutional home

    Correct: MERA-India = Malaria Elimination Research Alliance — INDIA. Under the Indian Council of Medical Research (ICMR). NOT under MoHFW directly or NCVBDC. ICMR coordinates research; NCVBDC coordinates programme implementation.

  • Trap · NVBDCP vs NCVBDC

    Correct: NVBDCP (National Vector Borne Disease Control Programme) was REORGANISED as NCVBDC (National Centre for Vector Borne Diseases Control). Same institutional lineage; updated nomenclature. Under MoHFW.

  • Trap · Ronald Ross and Charles Laveran timing/credit

    Correct: Charles Laveran DISCOVERED the Plasmodium PARASITE in 1880 (Algeria) — Nobel 1907. Ronald Ross demonstrated MOSQUITO TRANSMISSION in 1897 — Nobel 1902 (FIRST in malaria-related Nobels). Don't reverse the discoveries or years.

  • Trap · WHO founding and HQ

    Correct: WHO founded 7 APRIL 1948 (date now World Health Day). HQ GENEVA, Switzerland. 194 member states. Don't say HQ Lausanne, Brussels, or Lyon.

  • Trap · Malaria-free certified countries count

    Correct: 47 COUNTRIES certified malaria-free by WHO. NOT 25 (which is the vaccination-programme count) or 37 (which is countries with <1,000 cases in 2024). Three different metrics — don't conflate.

  • Trap · Africa Malaria Day origins

    Correct: Africa Malaria Day was established under the ABUJA DECLARATION (April 2000) by African Heads of State; first observed 25 April 2001. WHO replaced it with the global World Malaria Day in 2007/2008.

  • Trap · Sub-Saharan Africa malaria share

    Correct: Sub-Saharan Africa accounts for approximately 95% of malaria cases AND deaths globally. Highest burden region. Don't underestimate the regional concentration.

Flashcard

Q · World Malaria Day 2026 + India's malaria progress + global framework?tap to reveal
A · DATE: 25 April annually. THEME 2026: 'DRIVEN TO END MALARIA: NOW WE CAN. NOW WE MUST.' ESTABLISHED: World Health Organization (WHO); first observed 2008; replaced AFRICA MALARIA DAY (since 2001, Abuja Declaration). MALARIA: caused by PLASMODIUM parasites + transmitted by infected female ANOPHELES mosquitoes. 5 SPECIES: P. falciparum (most lethal, Africa) + P. vivax (most widespread incl India, relapsing) + P. malariae + P. ovale + P. knowlesi (zoonotic SE Asia). INDIAN VECTORS: A. culicifacies (rural N India) + A. stephensi (urban; recently spread to East Africa) + A. fluviatilis + A. minimus + A. dirus (NE forest). VACCINES: (1) RTS,S = FIRST; WHO Oct 2021; 30-40% effective; GlaxoSmithKline; Mosquirix (2) R21 = SECOND; WHO Oct 2023; more scalable; Serum Institute of India + Oxford; R21/Matrix-M. GLOBAL PROGRESS: 47 countries malaria-free certified; 37 countries <1,000 cases 2024; 25+ countries vaccination programmes; 84% nets are ITNs; ~610,000 deaths 2024; sub-Saharan Africa ~95% of cases+deaths. WHO GLOBAL TECHNICAL STRATEGY 2016-2030: 90% reduction by 2030 (vs 2015 baseline); eliminate from 35+ countries; 3 PILLARS: universal access + accelerate elimination + transform surveillance. INDIA: 80% reduction 2015-2023; >90% reduction in deaths; EXITED HBHI in 2024; target ELIMINATION BY 2030. PROGRAMMES: NVBDCP → NCVBDC (under MoHFW); MERA-India under ICMR; National Framework for Malaria Elimination 2016-2030. HISTORY: Charles Laveran discovered Plasmodium 1880 (Nobel 1907); Ronald Ross demonstrated mosquito transmission 1897 (Nobel 1902). WHO: founded 7 April 1948 (World Health Day); HQ Geneva; 194 members.

Suggested Reading

  • WHO World Malaria Report and Day overview
    search: who.int world malaria day 2026 theme global technical strategy 2016-2030
  • NCVBDC — India's vector-borne diseases control
    search: ncvbdc.mohfw.gov.in national framework malaria elimination india

Interlinkages

World Health Organization (WHO)WHO Global Technical Strategy for Malaria 2016-2030RTS,S malaria vaccineR21 malaria vaccineAnopheles mosquito (A. gambiae African; A. stephensi urban South Asia)Plasmodium parasites (5 human-infecting species)National Vector Borne Disease Control Programme (NVBDCP) → NCVBDCMinistry of Health and Family Welfare (MoHFW)Malaria Elimination Research Alliance (MERA-India)National Framework for Malaria Elimination 2016-2030High Burden to High Impact (HBHI) — India's exit 2024Insecticide-Treated Nets (ITNs)Gene drive technology (CRISPR-Cas9)Cartagena Protocol on Biosafety (2000)
Prerequisites · concepts to brush up first
  • WHO institutional architecture
  • Plasmodium parasite life cycle
  • Anopheles mosquito biology
  • India's vector-borne disease control programme architecture
  • RTS,S and R21 vaccine context
Topics
international/health/malariainternational/multilateral/whohealth/india/vector-borne-diseaseshealth/vaccines/rts-s-r21
Related stories
Back to 26 Apr 2026 bundle